# Intersecting Realms of Skin and Neurology in Systemic Lupus Erythematosus: A Systematic Review of Dermatological and Neurological Manifestations and Their Impact on Long-Term Prognosis

## TL;DR

This review explores how skin and neurological symptoms in lupus affect long-term outcomes, highlighting the need for integrated care.

## Contribution

The paper systematically reviews the intersection of dermatological and neurological manifestations in SLE and their impact on prognosis.

## Key findings

- Neuropsychiatric SLE is severe and linked to high disease activity and specific antibodies.
- Skin disease progression in SLE has systemic implications and affects prognosis.
- An interdisciplinary approach is needed to manage SLE effectively and improve patient outcomes.

## Abstract

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease characterized by diverse manifestations, notably in dermatological and neurological domains. This review aims to synthesize the current understanding of these manifestations and their impact on long-term prognosis.

Adhering to PRISMA guidelines, we conducted a comprehensive search across multiple databases, focusing on studies exploring SLE's dermatological and neurological aspects. Selected studies were analyzed to understand their epidemiology, pathophysiology, clinical presentation, and impact on prognosis.

Six pivotal studies were reviewed, highlighting the severity of neuropsychiatric SLE, the progression of skin diseases, and their systemic implications. Notably, studies underscored the role of high disease activity and specific antibodies in the development of neuropsychiatric symptoms and the progression of cutaneous manifestations.

The review emphasizes the need for an interdisciplinary approach to managing SLE, considering the interplay between its dermatological and neurological manifestations. It suggests that tailored treatment strategies, early detection, and comprehensive care are crucial for improving patient outcomes. This synthesis provides a foundation for future research to develop integrated care protocols and advance patient care in SLE.